Brief: Helius Medical Technologies Inc - Expansion Of Previously Announced Trial In Stroke From 12 To 60 Patients
July 27 (Reuters) - Helius Medical Technologies Inc
HSDT.O :
* HELIUS MEDICAL TECHNOLOGIES INC - EXPANSION OF PREVIOUSLY
ANNOUNCED TRIAL IN STROKE FROM 12 TO 60 PATIENTS
* HELIUS MEDICAL TECHNOLOGIES - MUSC ANTICIPATES ENROLLMENT
OF
SIXTY PARTICIPANTS WILL BEGIN IN AUGUST 2023, WITH EXPECTED
COMPLETION BY END OF 2024
Source text for Eikon: ID:nGNX5bZyL5
Further company coverage: HSDT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Solana Co
See all newsBrief: Solana Co Pursuant To Prospectus Supplement, May Offer Shares Of Common Stock Of Up To $250 Million From Time To Time
Brief: Solana: On May 12, Dane C. Andreeff Resigns As CEO, President And Board Member
Solana Co Q1 revenue surges on staking rewards
Brief: Solana Company (Nasdaq Hsdt) Appoints Madelene Gani As Chief Operating Officer And Deputy CFO To Lead Next Phase Of Growth
Solana Co Q4 revenue surges on staking rewards, swings to profit